<DOC>
	<DOC>NCT00994734</DOC>
	<brief_summary>The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.</brief_summary>
	<brief_title>Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Reproductive age women seeking abortion services. Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken. Participants must be eligible for medical abortion according to clinician and clinic standards. In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>